Volitionrx (VNRX) Operating Income (2012 - 2025)
Volitionrx (VNRX) posted Operating Income of -$4.8 million for Q4 2025, up 5.54% on a QoQ basis from -$5.1 million in Q3 2025, and up 16.66% year-over-year from -$4.1 million in Q4 2024.
Volitionrx (VNRX) Operating Income (2012 - 2025) Analysis & Trends
Volitionrx's Operating Income history runs 10 years deep, the most recent figure standing at -$4.8 million for Q4 2025.
- Quarterly Operating Income rose 16.66% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.7 million (up 19.56% YoY) and the FY2025 annual result came in at -$21.7 million, up 19.56% from the prior year.
- Operating Income was -$4.8 million for Q4 2025 at Volitionrx, up from -$5.1 million in the prior quarter.
- Across five years, Operating Income topped out at -$4.8 million in Q4 2025 and bottomed at -$9.5 million in Q2 2023.
- A 5-year average of -$7.2 million and a median of -$7.6 million in 2021 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2021 — Operating Income tumbled 67.89% — and 2025, when it soared 34.14%.
- Volitionrx's Operating Income stood at -$8.8 million in 2021, then climbed by 8.81% to -$8.0 million in 2022, then decreased by 9.11% to -$8.7 million in 2023, then soared by 33.86% to -$5.8 million in 2024, then gained by 16.66% to -$4.8 million in 2025.
- Business Quant data shows VNRX's Operating Income at -$4.8 million in Q4 2025, -$5.1 million in Q3 2025, and -$6.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | -4.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.82 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.52 Mn |
| Dec 31, 2024 | -5.78 Mn |
| Sep 30, 2024 | -5.87 Mn |
| Jun 30, 2024 | -6.99 Mn |
| Mar 31, 2024 | -8.38 Mn |
| Dec 31, 2023 | -8.74 Mn |
| Sep 30, 2023 | -8.65 Mn |
| Jun 30, 2023 | -9.55 Mn |
| Mar 31, 2023 | -9.05 Mn |
| Dec 31, 2022 | -8.01 Mn |
| Sep 30, 2022 | -7.99 Mn |
| Jun 30, 2022 | -8.10 Mn |
| Mar 31, 2022 | -7.68 Mn |
| Dec 31, 2021 | -8.79 Mn |
| Sep 30, 2021 | -7.56 Mn |
| Jun 30, 2021 | -5.90 Mn |
| Mar 31, 2021 | -6.09 Mn |